TABLE 1.
Clinical trials characteristics.
| Characteristics | N (%) |
|---|---|
| Conditions | |
| ADHD | 16 (84.2) |
| ADHD and Deficient Emotional Self-Regulation | 1 (5.3) |
| ADHD and Reading Disabilities | 1 (5.3) |
| ADHD, Conduct Disorder, and Oppositional Defiant Disorder | 1 (5.3) |
| Phases | |
| N/A | 2 (10.5) |
| Phase 1 | 2 (10.5) |
| Phase 1 and Phase 2 | 1 (5.3) |
| Phase 2 | 3 (15.8) |
| Phase 3 | 4 (21.1) |
| Phase 4 | 7 (36.8) |
| Allocation | |
| NA | 3 (15.8) |
| Non-randomized | 4 (21.1) |
| Randomized | 12 (63.2) |
| Intervention Model | |
| Single group | 5 (26.3) |
| Parallel | 8 (42.1) |
| Crossover | 6 (31.6) |
| Masking | |
| None | 8 (42.1) |
| Single | 1 (5.3) |
| Double | 4 (21.1) |
| Triple | 2 (10.5) |
| Quadruple | 4 (21.1) |
| Locations | |
| N/A | 3 (15.8) |
| Canada | 1 (5.3) |
| United States | 15 (78.9) |